Improving immune function in patients with Hidradenitis Suppurativa
Restoring Immune Balance in Hiddradenitis Suppurativa
This study is looking at how the immune system works in people with Hidradenitis Suppurativa to find new ways to treat this skin condition, and patients may have a chance to join in and help with the research.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10837087 on NIH RePORTER |
What this research studies
This research focuses on understanding the immune system's role in Hidradenitis Suppurativa (HS), a chronic inflammatory skin condition. The team at the UCSF Hidradenitis Suppurativa Center of Excellence is investigating how certain immune cells, particularly regulatory T cells, function in patients with HS. By examining the cellular and molecular mechanisms involved, the researchers aim to identify new treatment targets and develop more effective therapies for this debilitating disease. Patients may have the opportunity to participate in studies that explore these immune responses and their implications for treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Hidradenitis Suppurativa who are seeking new treatment options.
Not a fit: Patients with other skin conditions or those not diagnosed with Hidradenitis Suppurativa may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients suffering from Hidradenitis Suppurativa.
How similar studies have performed: Previous research has shown promise in understanding immune dysfunction in similar inflammatory conditions, suggesting potential for success in this area.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Rosenblum, Michael David — University of California, San Francisco
- Study coordinator: Rosenblum, Michael David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.